Related references
Note: Only part of the references are listed.Risk of mortality and complications in patients with schizophrenia and diabetes mellitus: population-based cohort study
Joe Kwun Nam Chan et al.
BRITISH JOURNAL OF PSYCHIATRY (2021)
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
Jose de Leon et al.
WORLD PSYCHIATRY (2020)
Clozapine treated patients and COVID-19: Ensuring continued care through collaboration
Jonathan G. Leung et al.
SCHIZOPHRENIA RESEARCH (2020)
Consensus statement on the use of clozapine during the COVID-19 pandemic
Dan Siskind et al.
JOURNAL OF PSYCHIATRY & NEUROSCIENCE (2020)
Cigarette Smoking by Patients With Serious Mental Illness, 1999-2016: An Increasing Disparity
Faith Dickerson et al.
PSYCHIATRIC SERVICES (2018)
Inflammation in Schizophrenia: Pathogenetic Aspects and Therapeutic Considerations
Norbert Mueller
SCHIZOPHRENIA BULLETIN (2018)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
Yuka Sugawara Kikuchi et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Optimizing clozapine treatment
J. Nielsen et al.
ACTA PSYCHIATRICA SCANDINAVICA (2011)
Systematic review: Agranulocytosis induced by nonchemotherapy drugs
Frank Andersohn et al.
ANNALS OF INTERNAL MEDICINE (2007)
Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring
PFJ Schulte
ANNALS OF PHARMACOTHERAPY (2006)
World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia
P Falkai et al.
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY (2005)
Share Paper
